Nanocomposited silicone hydrogels with a laser-assisted surface modification for inhibiting the growth of bacterial biofilm.

Surface and interface modifications of synthetic silicone hydrogels used for wearable and implantable medical devices, e.g. catheters and contact lenses, are critical to overcome their poor mechanical properties and biofouling. In this paper, silica nanoparticles (SiO2 NPs) were incorporated within silicone hydrogels through photo-polymerization. As compared to the silicone hydrogel, the nanocomposited silicone hydrogel shows highly textured microstructures, increased swelling behaviour and improved stiffness. Meanwhile, a hydrophilic surface of silicone hydrogel is important to minimize protein fouling which forms a conditioning layer for the growth of bacterial biofilm. Here, we applied matrix-assisted pulsed laser evaporation (MAPLE) with a pulsed Nd:YAG laser at 532 nm to deposit polyethylene glycol (PEG) on the surface of the nanocomposited silicone hydrogels. The PEG deposited on the nanocomposited silicone hydrogels forms islands at the submicron-scale, which increase with increasing irradiation time (t). The protein adsorption on nanocomposited silicone hydrogel with PEG deposition decreases over 40 ± 2% when t = 2 h. Compared to the commercial silicone catheters, the nanocomposited silicone hydrogel with PEG deposition can reduce the growth of bacteria from 1.20 × 106 CFU cm-2 to 3.69 × 105 CFU cm-2. In addition, the relative cell viabilities of NIH/3T3 mouse fibroblast cells treated using the nanocomposited silicone hydrogels coated with/without PEG were studied. No toxic effect is imposed on the cells. Consequently, the MAPLE process is a controllable, contamination-free technique to modify the surface of silicone hydrogels. We expect that the nanocomposited silicone hydrogels with appropriate surface treatment can be applied in various wearable and implantable medical devices.

Holmium:YAG laser endoureterotomy for treatment of ureteral stricture.

OBJECTIVES: Endourologic techniques ranging from balloon dilation to endoincision with electrocautery, cold knife, and lasers have been increasingly used in recent years for the treatment of ureteral strictures. While the long-term results may not be as reliable or as durable as traditional reconstructive surgical techniques, they can be accomplished with much less morbidity. Recently, the holmium:yttrium-aluminum-garnet (YAG) laser, which possesses both cutting and coagulating properties, has been demonstrated to have many applications in urology. We report our experience with this laser in the endoscopic treatment of ureteral strictures. METHODS: We reviewed the charts and follow-up history of 22 patients in whom the holmium:YAG laser was used to treat ureteral strictures from a variety of causes and including those in ureteroenteric anastomoses. Strictures were either approached in a retrograde fashion with a 6.9F ureteroscope or antegrade with flexible instruments in the cases involving ureteroenteric strictures. The only energy source employed was the laser, followed by balloon dilation. Indwelling stents were left in place for at least 4 weeks postoperatively and follow-up was obtained with radiographic imaging. RESULTS: A minimum 9-month follow-up was available for 18 patients. There were 5 patients who had developed recurrent strictures and were therefore considered treatment failures. Each of these patients failed in less than 3 months and all had either lengthy or complex strictures noted at the time of surgery. One patient was lost to follow-up and three recent patients have follow-up of 3 to 6 months showing no evidence of recurrent stricture formation. Overall, 16 of 21 (76%) patients are clinically well with no evidence of stricture recurrence. CONCLUSIONS: Endoureterotomy for ureteral stricture disease is a minimally invasive, less morbid, but ultimately less successful, alternative to open surgical reconstruction. Stricture length and etiology remain the most important determinants of success. The holmium:YAG laser, with its ability to precisely cut tissue and provide hemostasis and its multiuse potential and compatibility with small rigid and flexible endoscopic instruments, is an ideal tool for performing endoureterotomy.

Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial.

OBJECTIVES: To study the efficacy and safety of a new transurethral microwave thermotherapy device (the Urowave) in the treatment of men with clinical benign prostatic hyperplasia (BPH) in a randomized, double-blind, sham-controlled trial. METHODS: A total of 220 patients (mean age 66.2 years) with clinical BPH, an American Urological Association symptom index (AUA SI) of 13 points or more, and a peak flow rate of 12 mL/s or less were enrolled and randomized 2:1 for active versus sham treatment. All treatments were conducted as an outpatient procedure under local anesthesia, with oral sedation and analgesia only. Patients were followed up at 1 week and 1, 3, and 6 months after treatment. RESULTS: The treatments were well tolerated, and no patient received general or spinal anesthesia. The AUA SI dropped from 23.6 to 12.7 points at 6 months (P < 0.05) in the active group and from 23.9 to 18.0 points in the sham-treated group (P < 0.05, between-group difference). Statistically significant improvements were also noted for peak flow rate (7.7 to 10.7 mL/s at 6 months for active treatment, 8.1 to 9.8 mL/s for sham treatment, P < 0.05, between-group difference) and for average flow rate. A decrease in AUA SI of more than 30% was achieved in 72% versus 38% of patients (active versus sham treatment, respectively) and more than 50% in 50% versus 19% of patients. In general, active Urowave-treated patients perceived "a lot" of improvement, whereas sham-treated patients perceived "a little" to "some" improvement. More of the actively treated patients had dysuria and urgency after treatment, and ejaculatory dysfunction (e.g., hematospermia) was more common in actively treated patients as well. Secondary urinary retention after removal of the catheter occurred in 8 patients (5.4%). CONCLUSIONS: The Dornier Urowave transurethral microwave thermotherapy device for treatment of clinical BPH is effective in decreasing symptoms and bother and improving quality of life and flow rate and is superior to sham treatment. Patients perceive a great deal of improvement, independent of their baseline symptom severity. Adverse events are in general transient and mild in nature. Extended follow-up is necessary to document long-term durability of improvements.

Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation.

The oral administration of ciprofloxacin (250mg bid) and ofloxacin (300mg bid) in 40 patients with ureteral stents, led to drug levels on all the device surfaces that were higher than the minimum inhibitory concentration (MIC) of Escherichia coli (0.004--0.015 mg/l), the most common uropathogen. The drug levels in the film were higher than the MIC of other common pathogens, namely Pseudomonas aeruginosa (0.25--1.0 mg/l), Enterococcus faecalis (0.25--2.0 mg/l) and Staphylococcus aureus (0.12--0.5 mg/l) in a few cases (six, three and 14 cases out of 40, respectively). For both antibiotics, the concentrations were greater than the MIC of many uropathogens on the film surrounding the devices (0.89 vs 0.31 mg/l respectively, P=0.05), and on the devices themselves (0.22 vs. 0.12 mg/l, P=0.207). Adsorption of the antibiotics was higher to the film than to the stent (P<0.0001). Ciprofloxacin concentration on the film surrounding the stents was significantly higher than that of ofloxacin (P=0.05), while there was no statistical concentration difference between the two antibiotics adsorbed onto the actual devices (P=0.207). No bacteria were found in patients' urine and no biofilms were detected. This is the first report of an oral antibiotic being adsorbed onto medical devices. It potentially provides a new approach of preventing infection, and avoids the need to pre-coat devices with agents whose use will be restricted once bacteria develop resistance to them. If biomaterial properties can be enhanced to increase further the adsorptive concentration of drug, the risk of infections and recalcitrant biofilm formation could be significantly reduced in a highly susceptible patient population.

Contemporary management of ureteral stones.

The management of ureteral stones has undergone revolutionary changes in the past 15 years. The parallel advances in extracorporeal shock wave lithotripsy, percutaneous and retrograde endoscopic access to the collecting system, and intracorporeal lithotripsy devices almost completely have supplanted the need for a traditional ureterolithotomy. The merits of the various technologies that are available are discussed as they apply to treating calculi in different ureteral segments.

Intracorporeal lithotripsy. Update on technology.

The number and variety of devices currently available for endoscopic lithotripsy reflect the reality that no single device is ideal in all situations. Although the search for the universal lithotriptor continues, the urologist must consider several factors if faced with the decision of which device to purchase. Perhaps foremost among these factors is the clinical situation with which one commonly deals. For example, although the smaller, flexible probes such as EHL or laser demonstrate considerable utility if used ureteroscopically, the larger stone burden associated with today's percutaneous nephrolithotripsy population often is treated more efficiently with one of the mechanical devices employing a larger, rigid probe, such as ultrasound or the Lithoclast. Similarly, the type and size of endoscopic equipment at one's disposal have a significant impact on which device to purchase or use. There are physical constraints affecting which device may or may not be used, rigid versus flexible endoscope, working channel caliber, and offset versus end-on-port. The skill and experience of the surgeon is also a factor of obvious importance, particularly if one is using a modality with a relatively narrow margin of safety such as EHL. Likewise, the training and experience of nursing personnel is a factor, especially regarding the use of lasers, which require certified personnel who are well versed in laser safety. Finally, in today's environment one must carefully evaluate cost in terms of not only initial capital outlay but also ongoing charges for disposable and maintenance items. Thus, the decision of which device to purchase is complex and requires careful evaluation of all of the previously noted variables. Likewise, if one is fortunate enough to have more than one device available, the decision of which lithotriptor to employ requires a similar decision based on sound surgical judgment.

Imaging and the Internet.

Internet-based imaging is changing the way urology services are delivered by allowing rapid communication between remote locations. This review focuses on Internet-based imaging modalities, the hardware needed to transmit and view these images, and current applications. With the continuing expansion of Internet-based resources, all physicians must become accustomed to integrating the Internet and Internet-based imaging into their practices.

Use of Swiss Lithoclast for percutaneous nephrolithotripsy.

Despite the advent of extracorporeal shock wave lithotripsy, percutaneous nephrolithotripsy still plays a prominent role in the management of large and staghorn renal calculi. Modalities available for intracorporeal lithotripsy include ultrasound, electrohydraulic, and laser. I report my experience with the Swiss Lithoclast in performing percutaneous nephrolithotripsy in 45 patients. The advantages of this device in percutaneous stone removal include its rapidity, safety, ease of use, and usefulness in clearing the initial calix during staghorn stone removal.

Holmium: YAG laser resection of the prostate.

The holmium laser is a relatively new multipurpose medical laser that recently became available for use in urology. There has been considerable interest in this device, as it seems to combine the cutting properties of the carbon dioxide laser with the coagulating properties of the neodymium:YAG laser, making it particularly appealing for many surgical applications. The last decade has seen enthusiasm for the use of laser energy for the treatment of benign prostatic hyperplasia. In this article, we review the technique of Ho:YAG laser resection of the prostate, including the essential equipment and perioperative patient care.

Endourologic management of seminal vesicle cyst.

Cystic lesions in the region of the seminal vesicles, ejaculatory ducts, or prostate are rare and can be a diagnostic and therapeutic challenge. Open surgery is often necessary for definitive treatment. Recent refinements in transrectal ultrasound imaging and endoscopic instrumentation have expanded the roles of these modalities in the management of retrovesical cysts. We present a case in which a semirigid 6.9F ureteroscope was used to access and drain a seminal vesicle cyst transurethrally, thereby obviating open surgery.

Endoscopic management of ureteral injury after cesarean section.

Ureteral injury is an uncommon complication of cesarean section. As with all iatrogenic ureteral injuries, if the problem is not recognized intraoperatively, the manifestations may be protean. The management of ureteral injury that is first recognized in the early postoperative period must be individualized. We present a case of ureteral injury during a cesarean section in which endoscopic techniques were employed successfully to establish kidney drainage and allow ureteral healing, obviating open surgical repair.

Biomaterials in Urology II: future usage and management.

It seems likely, and indeed inevitable, that medical device usage will continue its rapid increase over the next 10 to 20 years and beyond. For surgeons, these new inventions will come in many forms but should take into account biocompatibility and resistance to encrustations and to microorganisms. This review focuses on research under way at present in vitro and in vivo on materials and coatings, use of bioelectrics, use of artificial organs and tissues, application of indigenous bacteria, and other alternative device management techniques, which could well become part of clinical practice in the future. By necessity, some of these citations are speculative, but supporting documentation for their inclusion is presented.

Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation.

This review focuses on the biomaterials used in urology, in particular, the properties of urethral catheters and ureteral stents currently being used in clinical practice. The importance of biomaterial type, biocompatibility, and encrustations are discussed and explained. Current management of bacterial infection and the importance of biofilms are presented, with recommendations based on published information.

Randomized trial of 10 mL and 20 mL of 2% intraurethral lidocaine gel and placebo in men undergoing flexible cystoscopy.

PURPOSE: To determine if 20 mL of 2% intraurethral lidocaine gel is superior to 10 mL of 2% lidocaine or sterile lubricant for flexible cystoscopy in men. PATIENTS AND METHODS: A randomized, double-blind, placebo-controlled trial was conducted. Sixty men scheduled to undergo diagnostic flexible cystoscopy were randomized to receive either 20 mL of placebo gel (Group I), 10 mL, of 2% lidocaine gel (Group II) or 20 mL of 2% lidocaine gel (Group III). A penile clamp was applied for 15 minutes to ensure consistent indwelling time in all patients. Patients recorded their pain on a 10-cm non-graphical visual analog scale prior to cystoscopy as a baseline, during the procedure, and immediately after the procedure. Patients also recorded their pain and willingness to have the same anesthetic on a 4-point descriptive scale. Heart rate and mean arterial blood pressure (MAP) were recorded at specific intervals throughout the procedure, and increases in mean arterial pressure were considered objective evidence of patient pain. RESULTS: Pain perception was not statistically different in the groups (Group I 4.65, Group II 3.93, Group III 3.57; P = 0.406). Pain assessment and willingness to have the same anesthetic also did not differ statistically among the groups. Similarly, differences in the increases in MAP were not statistically significant between groups. CONCLUSION: Instillation of 20 mL or 10 mL of 2% lidocaine gel has no advantage over plain lubricant in providing anesthesia for flexible cystoscopy in men.

Management of vesical calculi: comparison of lithotripsy devices.

Although endoscopic lithotripsy of bladder stones has been well described and is widely practiced, comparison of the main modalities of mechanical, electrohydraulic, and ultrasonic lithotripsy is lacking. The exact role of these and other modalities such as the Swiss Lithoclast and extracorporeal shockwave lithotripsy is not clearly defined. The safety and efficacy of the various lithotripsy modalities available to treat bladder calculi were reviewed retrospectively over an 18-year period. A total of 106 patients were treated with some form of intracorporeal lithotripsy. In general, all devices proved to be effective with a low rate of complications. The addition of transurethral resection of the prostate to bladder stone management under the same anesthetic was also found to be a safe procedure for moderate benign prostatic hyperplasia. In summary, transurethral endoscopic lithotripsy is a safe and effective method of bladder stone management both alone and in combination with transurethral prostatectomy. All modalities of intracorporeal lithotripsy are effective; however, devices such as ultrasound lithotripters or the Swiss Lithoclast that utilize larger, rigid probes may be more efficient for patients with large or particularly hard vesical calculi.

Electrical burn of urethra as cause of stricture after transurethral resection.

BACKGROUND AND PURPOSE: One of the most common complications of transurethral resection is urethral stricture. The exact etiology is still controversial. Postulated pathophysiology ranges from mechanical trauma to the urethra during the resection to inflammatory reaction secondary to local anesthesia. We propose electrical burn to the urethra as a contributory factor in some cases. MATERIALS AND METHODS: Electrical events during transurethral resection were simulated in vitro. The distribution of current was measured at the loop/rollerball and in the outer metal sheath. Both an intact loop/rollerball and loop/rollerball with faulty insulation were tested. Various power outputs simulating coagulation, cutting, and vaporization were used. Data were recorded both in settings where the outer metal sheath was and was not smeared with nonconductive lubricating gel. RESULTS: Approximately 20% of the total current output was shunted to the metal sheath when an intact loop/rollerball was used. One hundred percent of the current was short-circuited to the sheath when a loop/rollerball with faulty insulation was retracted into the sheath. Little current was detectable in the nonconductive lubricating gel. We then calculated the length of time required, in various settings, to reach tissue temperature of 45 degrees C, when protein denaturation starts. The higher the power output and the smaller the contacting surface area, the more likely it is for urethral burns to occur. CONCLUSION: Our in vitro experiment showed that urethral burns secondary to stray current in the resectoscope sheath are unlikely when an intact loop is used. However, urethral burns can occur when a loop/rollerball with faulty insulation is used, especially in combination with nonconductive gel that is dispersed unevenly within the urethra.

Ureteral lithotripsy with the electromechanical impactor.

Electrohydraulic lithotripsy (EHL) of ureteral calculi has proved to be an effective and relatively inexpensive method of intracorporeal lithotripsy. However, the potential for significant ureteral injury is an everpresent concern with conventional EHL. The electromechanical impactor (EMI), an innovative modification of a standard EHL probe, has been shown in initial investigations to be capable of fragmenting urinary calculi with a greater margin of safety. Herein, we describe our preliminary experience with this new device in 23 patients with ureteral calculi. In nine patients selected to undergo EMI treatment, the device could not be employed because of either inability to access the stone with the large endoscope required (six cases) or device malfunction (three cases). Among the patients in whom the EMI was used, five required an additional modality of intracorporeal lithotripsy to complete stone fragmentation. In the remaining nine patients, stone fragmentation was achieved with the EMI as the sole modality of lithotripsy, for an overall success rate of 39% (9/23). There were no complications directly related to use of the EMI as noted endoscopically or on postoperative imaging. The EMI appears to be a safe device for intracorporeal lithotripsy. Its application to a large population of patients with ureteral stones may be limited by the probe size (5F), which precludes its use with the smaller rigid and flexible ureteroscopes.

Identifying stone composition using infrared analysis of filtered urine after ureteroscopic lithotripsy.

BACKGROUND AND PURPOSE: With the development of small-caliber ureteroscopes and lithotripsy devices, it is now possible to perform intracorporeal stone fragmentation without dilatation of the ureteral orifice. Ureteral stones are typically fragmented into small particles that can be difficult to retrieve for stone analysis. Infrared spectroscopy (IRS) of the precipitate from urine after intracorporeal lithotripsy represents a method for obtaining stone analysis. PATIENTS AND METHODS: A total of 69 patients underwent ureteroscopic lithotripsy with the holmium laser or the electrohydraulic probe for stones in the ureter (N = 65) or kidney (N = 4). Each patient's bladder was then drained and the urine filtered. The resulting precipitate was analyzed using IRS. RESULTS: The amount of material for analysis was < or =1 mg in 56 patients (82%). Stone composition was positively identified in 44 patients (64%). Material suitable for analysis was recovered from 73% of patients when the bladder was drained with a cystoscope sheath compared with 43% when a urethral catheter was used (P = 0.03). There was no significant difference in pretreatment stone size in the patients who had a positive v a negative result (11.7 mm v 10.9 mm; P = 0.06). Similarly, the stone location was not significantly related to the likelihood of positive analysis (P = 0.29). CONCLUSION: Straining the urine after ureteroscopic intracorporeal lithotripsy and analyzing the precipitate with IRS is able to identify stone composition in the majority of patients. This method is especially useful in the setting of holmium laser lithotripsy, in which the majority of the stone is converted to spontaneously passable particles.

Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans.

Encrustation and urinary tract infection are problematic complications of ureteral stent usage. The objective of our first study was to use surface science techniques to examine three ureteral stent types for encrustation, biofilm formation, and antibiotic adsorption after use in patients. Black Beauty (N = 16), LSe (N = 16), and SofFlex (N = 32) ureteral stents were recovered from patients who had received trimethoprim or ciprofloxacin while the stent was indwelling. These stents were examined with X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy/energy-dispersive X-ray analysis (SEM/EDX) for the presence and composition of encrustation or biofilm. Conditioning films and encrustations were found on all stents. Encrustation elements (Ca, Mg, P) were identified on 11 of 16 Black Beauty (69%), 7 of 16 LSe (44%), and 12 of 32 SofFlex (38%) stents. The stent type, duration of insertion, and age or sex of the patient did not correlate significantly with the amount of encrustation. Bacterial biofilms were found on 1 of 7 Black Beauty stents (14%) and 7 of 32 SofFlex stents (22%). In a second study, an additional 28 patients with SofFlex stents were treated with ciprofloxacin (N = 16) or ofloxacin (N = 12). Their stents were subjected to high-performance liquid chromatography to determine if oral antibiotic therapy can lead to drug adsorption to the stent. Analysis showed that both ciprofloxacin and ofloxacin adsorbed to the stent surfaces. The mean concentrations of the two antibiotics within the conditioning film of the stents were 0.99 microg/mL and 0.34 microg/mL, respectively. These surface science techniques provide a comprehensive method of evaluating ureteral stents and other prosthetic devices in vivo.